fidexaban has been researched along with (z,z)-babch in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckman, BO; Davey, DD; Eagen, KA; Guilford, WJ; Hinchman, J; Ho, E; Koovakkat, S; Liang, A; Light, DR; Mohan, R; Morrissey, MM; Ng, HP; Phillips, GB; Post, JM; Shaw, KJ; Smith, D; Subramanyam, B; Sullivan, ME; Trinh, L; Vergona, R; Walters, J; White, K; Whitlow, M; Wu, S; Xu, W | 1 |
Buckman, BO; Koovakkat, S; Liang, A; Mohan, R; Morrissey, MM; Trinh, L | 1 |
Dallas, JL; Guilford, WJ; Koovakkat, S; Lee, W; Liang, A; Light, DR; McCarrick, MA; Morrissey, MM; Shaw, KJ; Whitlow, M; Ye, B | 1 |
3 other study(ies) available for fidexaban and (z,z)-babch
Article | Year |
---|---|
Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme fa
Topics: Administration, Oral; Amidines; Animals; Anticoagulants; Benzylidene Compounds; Binding Sites; Biological Availability; Cattle; Crystallography, X-Ray; Dogs; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Humans; Injections, Intravenous; Macaca fascicularis; Models, Molecular; Molecular Conformation; Papio; Pyridines; Serine Proteinase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Thrombin; Trypsin Inhibitors | 1998 |
Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors.
Topics: Animals; Anticoagulants; Binding Sites; Cattle; Drug Design; Factor Xa; Factor Xa Inhibitors; Humans; Indicators and Reagents; Kinetics; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Conformation; Pyrimidines; Structure-Activity Relationship; Thrombin; Trypsin Inhibitors | 1998 |
Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
Topics: Benzylidene Compounds; Factor Xa Inhibitors; Humans; Magnetic Resonance Spectroscopy; Serine Proteinase Inhibitors; Structure-Activity Relationship | 1999 |